Novo Nordisk

Oprah Winfrey Tackles Weight Loss Drug Stigma In Prime-Time Special Amid Wegovy-Ozempic Frenzy: 'For 25 Years, Making Fun Of My Weight Was National Sport'
US Health Agency Reviews Novo Nordisk's Wegovy For Potential Use In Treating Heart Disease Patients With Obesity
Ozempic Maker Novo Nordisk To Introduce Obesity Drug Wegovy In Japan, Acknowledging Country's Rising Weight Issue
US Health Agency Reviews Novo Nordisk's Wegovy For Potential Use In Treating Heart Disease Patients With Obesity
Ozempic Maker Novo Nordisk To Introduce Obesity Drug Wegovy In Japan, Acknowledging Country's Rising Weight Issue
Jim Cramer Says Nvidia, Eli Lilly, Novo Nordisk Are Not Overvalued: 'Will Be Ready To Buy If This Market Sells Off'
Ozempic Maker's Parent Company To Invest $7B Annually By 2030: 'We Have More Money Than Ever To Invest'

Novo Nordisk Recent News

Ozempic Users Might Experience Caloric Intake Rise Post-Discontinuation: Survey
Novo Nordisk's Wegovy has been linked to greater weight loss with prolonged use, with 40% of patients still using the drug a year later. This adherence rate is three times higher than other treatments.
Jim Cramer Highlights 'Transformational' Impact Of Weight Loss Drugs Like Ozempic: Focus Now On 'Potential Winners' From The Same Narrative
Novo Nordisk Ups Outlook Amid Surging Demand For Weight Loss Drug Wegovy, Ozempic
Following a surge in demand for its weight-loss drug Wegovy and diabetes medication Ozempic, Novo Nordisk has revised its full-year outlook.
Tempest Therapeutics, Microsoft, Birkenstock, Novo Nordisk, Tesla: Why These 5 Stocks Are On Investors' Radars Today
Major U.S. stock indices ended in the green on Wednesday, with the Nasdaq Composite marking notable gains of nearly 100 points.
Wegovy Maker Novo Nordisk, Akero Therapeutics, Eli Lilly, Athena Consumer Acquisition, Tesla: Why These 5 Stocks Are Trending Today
U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining around 130 points on Tuesday.
Experts Weigh In On Ozempic's Evolving Side Effects And How To Handle Them
Snacks In The Ozempic Era: Food, Beverage Stocks Crash With Weight Loss Drugs On The Rise
Food and beverage stocks endure their toughest week since May 2022, driven by concerns over weight-loss drugs and shifting consumer behavior.
Novo Nordisk Eyes Social Inequality To Enhance Access To Wegovy: 'Have To Be More Intentional'
Darcey Silva Accused Of Using 'Miracle' Drug Ozempic After Showing Dramatic Weight Loss
These Three New Markets May Propel Novo Nordisk's Ozempic To Greater Heights
Ozempic Competitor Wegovy Could Prevent 1.5M Heart Attacks And Strokes Over 10 Years, Study Reveals
Tracy Morgan Credits 'Miracle' Weight Loss Drug Ozempic For Shedding Pounds: 'I Ain't Letting It Go!'
Weight-Loss Drugs Ozempic, Wegovy Pose Life-Threatening Risks For Surgery And Anesthesia Patients: Expert Warns
Obesity Drug Wegovy Sales Jump 365% In H1 As Novo Nordisk Reports Solid Results, Raises FY23 Guidance
Ozempic Linked To Severe 'Roller Coaster Ride' Side Effects In Diabetic Patients
'Miracle' Weightloss Drugs Ozempic And Mounjaro Face Lawsuit Over Alleged Gastroparesis Side Effect
Shortage Of Elon Musk-Popularized 'Miracle' Weight-Loss Drug Puts Diabetic Patients In Peril, Regulator Warns
Raven-Symoné Criticizes Hollywood's Misuse Of Ozempic For 'Glamazon' Purposes: 'Save Some Medication For The People That Actually Need It'
'Ozempic Butt:' TikTok User Says 'Nothing To Brag About' After Popular Weight Loss Drug Leaves Her With Saggy Skin
Beware! Ozempic Has A Doppelganger And It Can Be Dangerous
'Miracle' Weight Loss Durg Ozempic's Has A Counterfeit In The Market – But It Has 'Life-Threatening' Consequences, Swiss Regulator Warns
European Regulator Expands Ozempic Probe To Include Other Weight Loss Drugs Over Suicide Risks
Novo Nordisk Charges Higher And Could Be Just Getting Started